TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
TriSalus Life Sciences, Inc. (TLSI)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $7.39 million, and the earnings are expected to come in at -$0.35 per share. The full year 2024's revenue is expected to be $29.36 million and the earnings are expected to be -$1.46 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 5 Warning Signs with TLSI. Over the past 90 days, revenue estimates for TriSalus Life Sciences Inc ( NASDAQ:TLSI ) for the full year 2024 have increased from $28.88 million to $29.36 million, while the estimates for 2025 have declined from $43.41 million to $43.25 million. Earnings estimates for the full year 2024 have improved from -$1.78 per share to -$1.46 per share, and for 2025, the estimates have risen from -$1.30 per share to -$1.18 per share. In the previous quarter of June 30, 2024, TriSalus Life Sciences Inc's ( NASDAQ:TLSI ) actual revenue was $7.36 million, which beat analysts' revenue expectations of $6.894 million by 6.82%. TriSalus Life
Show less
Read more
Impact Snapshot
Event Time:
TLSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLSI alerts
High impacting TriSalus Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
TLSI
News
- TriSalus Life Sciences, Inc. (NASDAQ: TLSI) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- TriSalus Reports Q3 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- TriSalus Reports Q3 2024 Financial Results and Provides Business UpdateBusiness Wire
- TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.MarketBeat
- TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
TLSI
Earnings
- 11/14/24 - Beat
TLSI
Sec Filings
- 11/15/24 - Form 4
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- TLSI's page on the SEC website